Importance of luxury flow for critically ill patients receiving a left ventricular assist system
- 21 December 2006
- journal article
- Published by Springer Nature in Journal of Artificial Organs
- Vol. 9 (4) , 209-213
- https://doi.org/10.1007/s10047-006-0355-y
Abstract
The presence of a significant organ dysfunction does not immediately exclude patients from consideration for treatment with a left ventricular assist system (LVAS). However, in treating morbid circulatory shock patients with multiple organ failure, it is important to know the preoperative and postoperative factor or factors related to the recovery of the damaged organ function. In this study, we retrospectively analyzed patients receiving a LVAS at our institution and tried to determine the important factors related to the survival of patients with multisystem failure. Twenty-seven patients who underwent LVAS placement at Saitama Medical School Hospital between 1993 and 2003 were included in this study. The preoperative risk factors analyzed were renal dysfunction, respiratory dysfunction, hepatic dysfunction, the existence of active infection, and the combination of all four factors. As a postoperative factor, the pump flow index (mean LVAS pump flow during the first 2 weeks after LVAS surgery divided by the body surface area) was analyzed. None of the analyzed preoperative factors could predict survival after LVAS surgery, but a pump flow index of less than 2.5 l/min/m2 had a significant relationship with death after LVAS surgery. Further analysis revealed that all the patients with a pump flow index of 3.0 l/min/m2 or more could overcome preoperative organ dysfunction. Congestive heart failure patients with multisystem failure need luxury pump flow for successful LVAS surgery; this factor could be especially important in device selection and postoperative management.Keywords
This publication has 14 references indexed in Scilit:
- Patient selection for left ventricular assist device therapyThe Annals of Thoracic Surgery, 2003
- Revised screening scale to predict survival after insertion of a left ventricular assist deviceThe Journal of Thoracic and Cardiovascular Surgery, 2003
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001
- Application of “double bridge mechanical” resuscitation for profound cardiogenic shock leading to cardiac transplantationThe Annals of Thoracic Surgery, 2001
- Mechanical Circulatory Support for Advanced Heart FailureCirculation, 2001
- One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technologyThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Percutaneous cardiopulmonary support system as a bridge to left ventricular assist system (LVAS) implantation: Analysis of its role in the treatment of end-stage cardiac diseaseJournal of Artificial Organs, 1998
- Success Rates of Long-Term Circulatory Assist Devices Used Currently for Bridge to Heart TransplantationPublished by Wolters Kluwer Health ,1996
- Screening Scale Predicts Patients Successfully Receiving Long-term Implantable Left Ventricular Assist DevicesCirculation, 1995
- Improved survival after extended bridge to cardiac transplantationThe Annals of Thoracic Surgery, 1994